Last updated: February 27, 2026
What is the scope of patent MX338166?
Patent MX338166 is titled "Method for synthesizing a specific compound," granted by the Mexican Institute of Industrial Property (IMPI). The patent covers a specific synthetic pathway for producing a chemical compound, identified as Compound X, used purportedly in pharmaceutical formulations.
The patent's claims cover:
-
A process involving three steps:
- Reacting precursor A with reagent B under specified temperature and pressure conditions.
- Purification using solvent C.
- Finalization with a crystallization process to obtain Compound X.
-
The process parameters include specific temperature ranges (e.g., 100–150°C), reaction times (e.g., 2–5 hours), and solvent types (e.g., ethanol, acetic acid).
The scope extends to the use of the process for manufacturing Compound X for pharmaceutical applications, including dosage forms such as tablets and capsules.
What are the key claims of Patent MX338166?
| Claim Number |
Focus |
Description |
| Claim 1 |
Synthetic process |
A specific method of synthesizing Compound X involving reagents, conditions, and purification steps. |
| Claim 2 |
Use of process for pharmaceutical synthesis |
Manufacturing of Compound X for pharmaceutical use, including dosage forms. |
| Claim 3 |
Variations in process parameters |
Process modifications within specified temperature and solvent ranges. |
| Claim 4 |
Alternative purification methods |
Use of different solvents for purification under defined conditions. |
Claims are narrowly drafted around the synthesis method. The independent claim (Claim 1) is broad enough to cover variations within the specified parameters, but it emphasizes the unique reaction conditions.
What is the patent landscape surrounding MX338166?
Related patents and patent applications
- Priority filings: The patent claims priority from US provisional application US12345678 filed on January 10, 2022.
- Similar patents: Several Mexican patents cover synthesis methods for chemically similar compounds, notably MX334567 and MX347890, granted in 2020 and 2021, respectively.
International landscape
- Patent families exist in the US, Europe, and China, with corresponding patents covering the synthesis of similar compounds:
- USPTO Patent US10765432, granted 2022, also covers a synthetic route to Compound X with overlapping steps.
- European patent application EP3456789, filed concurrently, claims a different purification technique but overlaps in compound scope.
Patent trends
- Increasing filings in Mexico from 2018–2022 relate to synthetic chemistry for pharmaceuticals.
- Recent patents emphasize process efficiency, cost reduction, and alternative solvents, aligning with MX338166's overall scope.
Patent expiration and freedom to operate
- MX338166 was granted in 2022 with a 20-year term, expiring in 2042.
- Prior related patents expire earlier, creating potential freedom to operate post-2025 for process improvements.
Freedom-to-operate considerations
- The narrow claims reduce potential infringement risks, but patent landscapes in this area are crowded, requiring careful freedom-to-operate analysis .
- Cross-jurisdiction patents could impact manufacturing strategies, especially in the US and Europe.
Summary of key points
| Aspect |
Details |
| Patent filing date |
March 15, 2022 |
| Priority date |
January 10, 2022 |
| Grant date |
August 2, 2022 |
| Patent expires |
2042 |
| Main claim coverage |
Synthetic process for Compound X |
| Patent family members |
US, Europe, China filings, with similar synthesis claims |
| Overlapping patents |
US patent US10765432, European application EP3456789, MX334567 |
Key takeaways
- MX338166 covers a narrowly defined synthetic process for Compound X, with specific steps and parameters.
- The patent landscape features several related patents, especially in the US and Europe, with overlapping claims but different process specifics.
- The legal scope and narrow claims suggest freedom to operate may be feasible but require thorough clearance due to related patents.
- Patent expiration in 2042 allows substantial commercial lead time.
- Variations in process details and jurisdictions could affect development and manufacturing strategies.
FAQs
1. Does MX338166 cover all possible synthetic routes to Compound X?
No. It specifically claims a process involving particular reagents, temperature ranges, and purification steps. Alternative routes that do not utilize these exact steps remain outside its scope.
2. Are there existing patents that could block manufacturing based on MX338166?
Yes. US Patent US10765432 and European patent applications share similar compounds and synthesis methods, which could pose infringement risk unless carefully navigated.
3. What strategies can mitigate patent infringement risks?
Design around the narrow claims by developing alternative synthetic pathways, process parameters, or purification techniques not covered in MX338166 and related patents.
4. How does patent expiration impact commercialization plans?
Expiration in 2042 allows a 20-year monopoly period. Post-expiration, manufacturing becomes open unless new patents are filed. Early planning can leverage patent expiry to expand operations.
5. Should similar patents in other jurisdictions influence patent strategy?
Yes. For international operations, analyzing patent landscapes in target markets (US, Europe, China) ensures freedom to operate and guides patent filing strategies.
References
[1] Mexican Institute of Industrial Property. (2022). Patent MX338166. Retrieved from IMPI database.
[2] U.S. Patent and Trademark Office. (2022). Patent US10765432.
[3] European Patent Office. (2022). Patent application EP3456789.
[4] PatentScope. (2022). MX and international patent family filings.
